HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,497,451,049 | +12.7% | 21,587,441 | +0.2% | 0.06% | +15.1% |
Q2 2023 | $2,215,854,293 | -5.8% | 21,544,524 | -0.0% | 0.05% | -11.7% |
Q1 2023 | $2,352,319,850 | -2.7% | 21,553,233 | +1.5% | 0.06% | -9.1% |
Q4 2022 | $2,416,668,523 | +83.5% | 21,236,103 | -0.2% | 0.07% | +69.2% |
Q3 2022 | $1,316,812,000 | -21.1% | 21,276,662 | +1.7% | 0.04% | -17.0% |
Q2 2022 | $1,668,768,000 | -22.0% | 20,922,375 | +2.9% | 0.05% | -7.8% |
Q1 2022 | $2,138,801,000 | -1.4% | 20,328,877 | +0.9% | 0.05% | +4.1% |
Q4 2021 | $2,170,145,000 | -1.1% | 20,138,694 | +0.6% | 0.05% | -9.3% |
Q3 2021 | $2,193,540,000 | +17.6% | 20,025,013 | +0.5% | 0.05% | +17.4% |
Q2 2021 | $1,865,884,000 | -1.1% | 19,926,152 | -2.8% | 0.05% | -9.8% |
Q1 2021 | $1,887,225,000 | +29.5% | 20,504,397 | +2.9% | 0.05% | +21.4% |
Q4 2020 | $1,457,166,000 | -2.6% | 19,920,258 | +3.5% | 0.04% | -14.3% |
Q3 2020 | $1,495,562,000 | +51.6% | 19,252,850 | +8.4% | 0.05% | +40.0% |
Q2 2020 | $986,797,000 | +89.9% | 17,754,535 | +1.2% | 0.04% | +59.1% |
Q1 2020 | $519,676,000 | -16.0% | 17,544,776 | +2.7% | 0.02% | +4.8% |
Q4 2019 | $618,636,000 | +33.7% | 17,089,414 | +0.5% | 0.02% | +23.5% |
Q3 2019 | $462,854,000 | +15.9% | 16,997,944 | +2.4% | 0.02% | +13.3% |
Q2 2019 | $399,255,000 | – | 16,594,128 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |